Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major.

Dimitriadou M, Christoforidis A, Fidani L, Economou M, Vlachaki E, Athanassiou-Metaxa M, Katzos G.

Osteoporos Int. 2016 Feb;27(2):781-8. doi: 10.1007/s00198-015-3264-1. Epub 2015 Aug 15.

PMID:
26275438
2.

FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome.

Papagianni A, Economou M, Tragiannidis A, Karatza E, Samarah F, Gombakis N, Athanassiadou-Piperopoulou F, Vavatsi-Christaki N, Athanassiou-Metaxa M.

Blood Coagul Fibrinolysis. 2013 Jan;24(1):35-9. doi: 10.1097/MBC.0b013e328359bc3b.

PMID:
23249566
3.

Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin.

Teli A, Economou M, Rudolf J, Tzovaras F, Gourtsa V, Kondou A, Kontopoulos E, Gombakis N, Athanassiou-Metaxa M, Zafeiriou D.

Blood Coagul Fibrinolysis. 2012 Apr;23(3):195-202. doi: 10.1097/MBC.0b013e32834f0ac0.

PMID:
22322135
4.

Congenital hypothyroidism as the initial presentation that led to the diagnosis of Williams syndrome.

Dimitriadou M, Christoforidis A, Sarri C, Gyftodimou Y, Athanassiou-Metaxa M.

Gene. 2012 Feb 15;494(1):102-4. doi: 10.1016/j.gene.2011.12.007. Epub 2011 Dec 14. No abstract available.

PMID:
22198067
5.

Transfusion-related acute lung injury management in a pediatric intensive care unit.

Dotis J, Stabouli S, Violaki A, Vogiatzi L, Mitroudi M, Oikonomou M, Athanassiou-Metaxa M, Kotsiou M.

Hippokratia. 2011 Apr;15(2):184-6.

6.

Defining overweight and obesity among Greek children living in Thessaloniki: International versus local reference standards.

Christoforidis A, Dimitriadou M, Papadopolou E, Stilpnopoulou D, Katzos G, Athanassiou-Metaxa M.

Hippokratia. 2011 Apr;15(2):141-6.

7.

Fok-I polymorphism of vitamin D receptor gene and the presence of renal dysfunction in patients with β-thalassemia major.

Dimitriadou M, Christoforidis A, Economou M, Teli A, Printza N, Tzimouli V, Tsatra I, Fidani L, Papachristou F, Athanassiou-Metaxa M.

Pediatr Hematol Oncol. 2011 Sep;28(6):509-16. doi: 10.3109/08880018.2011.579231. Epub 2011 Jul 15.

PMID:
21762013
8.

Use of propranolol in infantile haemangiomas: report of five cases and review of the literature.

Gidaris D, Economou M, Hatzidemetriou V, Gombakis N, Athanassiou-Metaxa M.

Hippokratia. 2011 Jan;15(1):81-3.

9.

Cross-sectional study of pulmonary function and MRI-derived liver and myocardial iron content in young patients with β-thalassemia major.

Dimitriadou M, Christoforidis A, Bourli E, Perifanis V, Economou M, Teli A, Pataka A, Stanopoulos I, Argyropoulou P, Athanassiou-Metaxa M.

Eur J Haematol. 2011 Sep;87(3):279-80. doi: 10.1111/j.1600-0609.2011.01633.x. Epub 2011 Jul 26. No abstract available.

PMID:
21535156
10.

Fok-I gene polymorphism of vitamin D receptor in patients with beta-thalassemia major and its effect on vitamin D status.

Dimitriadou M, Christoforidis A, Fidani L, Economou M, Perifanis V, Tsatra I, Katzos G, Athanassiou-Metaxa M.

Hematology. 2011 Jan;16(1):54-8. doi: 10.1179/102453311X12902908411878.

PMID:
21269569
11.

Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia.

Hatzipantelis ES, Athanassiou-Metaxa M, Gombakis N, Tzimouli V, Taparkou A, Sidi-Fragandrea V, Garipidou V, Papageorgiou T, Kleta D, Koliouskas DE, Athanasiadou-Piperopoulou F.

Acta Haematol. 2011;125(3):130-5. doi: 10.1159/000322120. Epub 2010 Dec 11.

PMID:
21150180
12.

Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia.

Christoforidis A, Economou M, Papadopoulou E, Kazantzidou E, Farmaki E, Tzimouli V, Tsatra I, Gompakis N, Athanassiou-Metaxa M.

Haemophilia. 2011 Jan;17(1):e217-22. doi: 10.1111/j.1365-2516.2010.02385.x. Epub 2010 Sep 2.

PMID:
20825502
13.

Bone status of children with hemophilia A assessed with quantitative ultrasound sonography (QUS) and dual energy X-ray absorptiometry (DXA).

Christoforidis A, Economou M, Papadopoulou E, Kazantzidou E, Gompakis N, Athanassiou-Metaxa M.

J Pediatr Hematol Oncol. 2010 Oct;32(7):e259-63. doi: 10.1097/MPH.0b013e3181e8cd40.

PMID:
20736845
14.

Haematuria in a young patient with severe haemophilia and inhibitor presence receiving prophylactic treatment with recombinant factor VIIa.

Economou M, Papadopoulou E, Vagianou I, Farmaki E, Gompakis N, Athanassiou-Metaxa M.

Blood Coagul Fibrinolysis. 2010 Sep;21(6):611-3. doi: 10.1097/MBC.0b013e32833c2b79. No abstract available.

PMID:
20703104
15.

Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.

Economou M, Printza N, Teli A, Tzimouli V, Tsatra I, Papachristou F, Athanassiou-Metaxa M.

Acta Haematol. 2010;123(3):148-52. doi: 10.1159/000287238. Epub 2010 Feb 24.

PMID:
20185899
16.

A case of mild thalassemic syndrome caused by interaction of Hb Adana with an alpha+-thalassemia deletion.

Economou M, Papadopoulou E, Tsatra I, Athanassiou-Metaxa M.

J Pediatr Hematol Oncol. 2010 Mar;32(2):167-8. doi: 10.1097/MPH.0b013e3181c5ab89. No abstract available. Erratum in: J Pediatr Hematol Oncol. 2010 May;32(4):331. Marina, Economou [corrected to Economou, Marina]; Eleni, Papadopoulou [corrected to Papadopoulou, Eleni]; Ioanna, Tsatra [corrected to Tsatra, Ioanna];Miranda, Athanassiou-Metaxa [corrected to Athanassiou-Metaxa, Miranda].

PMID:
20147853
17.

CMV-related immune thrombocytopenic purpura or CMV-induced thrombocytopenia?

Papagianni A, Economou M, Tsoutsou E, Athanassiou-Metaxa M.

Br J Haematol. 2010 May;149(3):454-5. doi: 10.1111/j.1365-2141.2009.08064.x. Epub 2010 Jan 20. No abstract available.

PMID:
20096016
18.

Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia.

Christoforidis A, Economou M, Farmaki E, Tzimouli V, Gombakis N, Athanassiou-Metaxa M.

Ann Hematol. 2010 Aug;89(8):837-8. doi: 10.1007/s00277-009-0894-4. Epub 2010 Jan 19. No abstract available.

PMID:
20084381
19.

Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major.

Dimitriadou M, Christoforidis A, Economou M, Tsatra I, Vlachaki E, Fidani L, Katzos G, Athanassiou-Metaxa M.

Eur J Haematol. 2010 Jan 1;84(1):64-71. doi: 10.1111/j.1600-0609.2009.01349.x. Epub 2009 Sep 10.

PMID:
19744128
20.

Reference values for quantitative ultrasonography (QUS) of radius and tibia in healthy greek pediatric population: clinical correlations.

Christoforidis A, Papadopoulou E, Dimitriadou M, Stilpnopoulou D, Gkogka C, Katzos G, Athanassiou-Metaxa M.

J Clin Densitom. 2009 Jul-Sep;12(3):360-8. doi: 10.1016/j.jocd.2009.03.097. Epub 2009 Jul 4.

PMID:
19577938
21.

MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations.

Christoforidis A, Perifanis V, Spanos G, Vlachaki E, Economou M, Tsatra I, Athanassiou-Metaxa M.

Eur J Haematol. 2009 May;82(5):388-92. doi: 10.1111/j.1600-0609.2009.01223.x. Epub 2009 Jan 9.

PMID:
19141120
22.

The compatible MRI scoring system for staging of haemophilic arthropathy.

Fotiadis N, Ekonomou I, Haritanti A, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS.

Haemophilia. 2008 Jul;14(4):866-7. doi: 10.1111/j.1365-2516.2008.01778.x. Epub 2008 May 22. No abstract available.

PMID:
18505460
23.

Immune and neural status of thalassemic patients receiving deferiprone or combined deferiprone and deferoxamine chelation treatment.

Tourkantoni N, Athanassiou-Metaxa M, Zafiriou D, Tzimouli V, Economou M, Taparkou A, Perifanis V, Kanakoudi-Tsakalidou F.

Hemoglobin. 2008;32(1-2):35-40. doi: 10.1080/03630260701680631.

PMID:
18274981
24.

Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.

Economou M, Teli A, Tzantzaroudi A, Tsatra I, Zavitsanakis A, Athanassiou-Metaxa M.

Haemophilia. 2008 Mar;14(2):390-1. doi: 10.1111/j.1365-2516.2007.01635.x. Epub 2008 Jan 10. No abstract available.

PMID:
18194305
25.

comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major.

Perifanis V, Christoforidis A, Vlachaki E, Tsatra I, Spanos G, Athanassiou-Metaxa M.

Int J Hematol. 2007 Dec;86(5):385-9. doi: 10.1532/IJH97.E0734.

PMID:
18192103
26.

Tibial pseudotumor in a child with hemophilia.

Hatzipantelis ES, Athanassiou-Metaxa M, Koussi A, Tsatra I, Badouraki M, Tsayias I, Gombakis N.

Pediatr Hematol Oncol. 2007 Dec;24(8):623-30.

PMID:
18092253
27.

Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major.

Christoforidis A, Kazantzidou E, Tsatra I, Tsantali H, Koliakos G, Hatzipantelis E, Katzos G, Athanassiou-Metaxa M.

Hormones (Athens). 2007 Oct-Dec;6(4):334-40.

28.

Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients.

Tsapas A, Vlachaki E, Christoforidis A, Sarigianni M, Bekiari E, Perifanis V, Tsapas V, Paletas K, Athanassiou-Metaxa M.

Eur J Haematol. 2007 Dec;79(6):526-30. Epub 2007 Oct 23.

PMID:
17961176
29.

Bone age estimation and prediction of final height in patients with beta-thalassaemia major: a comparison between the two most common methods.

Christoforidis A, Badouraki M, Katzos G, Athanassiou-Metaxa M.

Pediatr Radiol. 2007 Dec;37(12):1241-6. Epub 2007 Oct 19.

PMID:
17952427
30.

Urinary iron excretion in young thalassemic patients receiving combined chelation treatment with deferoxamine and deferiprone.

Christoforidis A, Zevgaridou E, Tsatra I, Perifanis V, Vlachaki E, Papassotiriou I, Apostolakou F, Athanassiou-Metaxa M.

J Pediatr Hematol Oncol. 2007 Sep;29(9):598-601.

PMID:
17805032
31.

Evaluation of serum tumour markers concentrations in patients with homozygous beta-thalassaemia in relation to demographical, clinical and biochemical parameters.

Christoforidis A, Lefkou E, Vlachaki E, Perifanis V, Tsatra I, Dogramatzi F, Athanassiou-Metaxa M.

Ann Hematol. 2007 Nov;86(11):837-41. Epub 2007 Aug 1.

PMID:
17668208
32.

MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.

Christoforidis A, Haritandi A, Perifanis V, Tsatra I, Athanassiou-Metaxa M, Dimitriadis AS.

Eur J Radiol. 2007 Apr;62(1):138-42. Epub 2006 Dec 11.

PMID:
17161570
33.

Peripheral blood haematopoietic progenitor cells in patients with beta thalassaemia major receiving desferrioxamine or deferiprone as chelation therapy.

Vlachaki E, Ioannidou-Papagiannaki E, Tziomalos K, Haralambidou-Vranitsa S, Perifanis V, Klonizakis I, Athanassiou-Metaxa M.

Eur J Haematol. 2007 Jan;78(1):48-51. Epub 2006 Oct 17.

PMID:
17042774
34.

Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens.

Christoforidis A, Haritandi A, Tsatra I, Tsitourides I, Karyda S, Athanassiou-Metaxa M.

Eur J Haematol. 2007 Jan;78(1):52-7. Epub 2006 Sep 28.

PMID:
17042760
35.

Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.

Perifanis V, Vyzantiadis T, Tziomalos K, Vakalopoulou S, Garipidou V, Athanassiou-Metaxa M, Harsoulis F.

Ann Hematol. 2007 Jan;86(1):23-30. Epub 2006 Sep 30.

PMID:
17013645
36.

Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major.

Christoforidis A, Perifanis V, Athanassiou-Metaxa M.

Br J Haematol. 2006 Oct;135(2):271-2. Epub 2006 Sep 11. No abstract available.

PMID:
16965387
37.

Evolution of OGTT in patients with beta-thalassaemia major in relation to chelation therapy.

Christoforidis A, Perifanis V, Tsatra I, Vlachaki E, Athanassiou-Metaxa M.

Diabetes Res Clin Pract. 2007 Apr;76(1):6-11. Epub 2006 Aug 22.

PMID:
16930760
38.

Transfusion-related immune hemolytic anemia in thalassemic patients: report of 2 cases.

Koussi A, Economou M, Gompakis N, Athanassiou-Metaxa M, Pliaki P.

J Pediatr Hematol Oncol. 2006 Jun;28(6):402. No abstract available.

PMID:
16794513
39.

Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.

Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S, Dimitriadis AS, Athanassiou-Metaxa M.

J Pediatr Hematol Oncol. 2006 May;28(5):311-5.

PMID:
16772883
40.

Bone mineral density in children and young adults with beta-thalassemia major conventionally treated.

Christoforidis A, Hatzipantelis E, Tsatra I, Kazantzidou E, Katzos G, Athanassiou-Metaxa M.

Pediatr Blood Cancer. 2006 Jul;47(1):113-4; author reply 115. No abstract available.

PMID:
16602118
41.

Transfusion related acute lung injury syndrome (TRALI) in a patient with thalassaemia.

Koussi A, Trachana M, Pliaki P, Gombakis N, Athanassiou-Metaxa M.

Pediatr Blood Cancer. 2006 Jun;46(7):829-30; author reply 831. No abstract available.

PMID:
16514613
42.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D.

Blood. 2006 May 1;107(9):3455-62. Epub 2005 Dec 13.

PMID:
16352812
43.

Prevalence and severity of liver disease in patients with b thalassemia major. A single-institution fifteen-year experience.

Perifanis V, Tziomalos K, Tsatra I, Karyda S, Patsiaoura K, Athanassiou-Metaxa M.

Haematologica. 2005 Aug;90(8):1136-8.

44.

Neurophysiologic and intellectual evaluation of beta-thalassemia patients.

Economou M, Zafeiriou DI, Kontopoulos E, Gompakis N, Koussi A, Perifanis V, Athanassiou-Metaxa M.

Brain Dev. 2006 Jan;28(1):14-8. Epub 2005 May 31.

PMID:
15925466
45.

Long term audiological evaluation of beta-thalassemic patients.

Kontzoglou G, Koussi A, Economou M, Tsatra I, Perifanis V, Noussios G, Athanassiou-Metaxa M.

Acta Otorhinolaryngol Belg. 2004;58(2):113-7.

PMID:
15515654
46.

Subclinical celiac disease in children: refractory iron deficiency as the sole presentation.

Economou M, Karyda S, Gombakis N, Tsatra J, Athanassiou-Metaxa M.

J Pediatr Hematol Oncol. 2004 Mar;26(3):153-4; author reply 154. No abstract available.

PMID:
15125605
47.

Combined chelation therapy with deferiprone and desferrioxamine in iron overloaded beta-thalassemia patients.

Athanassiou-Metaxa M, Kousi A, Hatzipantelis ES, Tsatra I, Ikonomou M, Perifanis V, Tsantali H.

Haematologica. 2004 Apr;89(4):ELT07. No abstract available.

48.

Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.

Perifanis V, Vyzantiadis T, Vakalopoulou S, Tziomalos K, Garypidou V, Athanassiou-Metaxa M, Harsoulis F.

Br J Haematol. 2004 Apr;125(1):91-2; author reply 93-4. No abstract available.

PMID:
15015977
49.

Evaluation of iron overload in beta-thalassemia patients using magnetic resonance imaging.

Perifanis V, Economou M, Christoforides A, Koussi A, Tsitourides I, Athanassiou-Metaxa M.

Hemoglobin. 2004 Feb;28(1):45-9. No abstract available.

PMID:
15008264
50.

Immune status of thalassemic patients receiving deferiprone or combined deferiprone and desferrioxamine chelation treatment.

Athanassiou-Metaxa M, Tzimouli V, Economou M, Taparkou A, Tourkantoni N, Kanakoudi-Tsakalidou F.

Acta Haematol. 2003;110(4):224-6. No abstract available.

PMID:
14663175

Supplemental Content

Loading ...
Support Center